Can you imagine how exclusivity showcased the critical importance of adaptable strategies in the pharmaceutical industry? In this episode, embark on an illuminating journey through the evolution of pharmaceutical marketing as your host Soumya Prakash engages in a thought-provoking dialogue with industry luminary Salil Kallianpur. In this podcast Mr. Salil Kallianpur, a pharma veteran shares with you the transition from sales to marketing, from earning an MBA and joining Dr. Reddy's. This was the turning moment of his life. Where he learned strategic thinking and creative problem-solving. After a brief stint at Novartis, he joined Pfizer, and leveraged his cardiology expertise. His nine-year period at Pfizer marked a significant phase in his pharmaceutical career. We take a compelling look into: The shift from science-based selling to strategic marketing in pharma's pre-digital era. Cultural understanding as the cornerstone of successful international pharma strategies. The critical need for value creation in customer engagement, beyond product-centric approaches. The potential and pitfalls of AI adoption in pharma marketing without proper data infrastructure. Salil Kallianpur's insights reveal the complex interplay between science, culture, and technology in shaping pharmaceutical marketing. As the industry stands at the crossroads of traditional practices and digital innovation, success hinges on balancing data-driven strategies with human-centric approaches. The future of pharma marketing lies not just in adopting new technologies, but in fundamentally rethinking value creation for healthcare professionals and patients alike. This episode offers rich insights into diverse pharmaceutical markets, from Russia to the Middle East, Africa, Gulf, and CIS countries, highlighting their unique characteristics. ***** Pharma Marketing Playbook Podcast is brought to you by Multiplier AI, a leading force in the Healthcare industry providing data and Gen AI driven pharma and physician marketing to global brands. Know more about us at: https://www.multiplierai.co/ About the guest: Mr. Salil Kallianpur began his career as a Scientific Officer at Serdia Pharmaceuticals. Over the past two decades, he has advanced to key roles, including Head of Marketing at Pfizer Ltd. and Executive Vice President at GSK. He has also held significant positions at Dr. Reddy's Laboratories and Novartis. Currently, Salil is the Founder and Managing Director of Arks Knowledge Consulting Pvt Ltd and a visiting professor at SVKM's Narsee Monjee Institute of Management Studies. As an industry expert, he brings a wealth of experience and insight to our show . Linkedin Profile:https://www.linkedin.com/in/salilkallianpur/ About the host: Saumya Prakash is the Co-Founder of Mutiplier AI coming in with a remarkable track record in the healthcare sector. She is a seasoned entrepreneur and tech expert with a profound understanding of AI and IT Software. She holds an MBA from SP Jain Institute of Management and a B. Tech in Computer Science from BITS Pilani, where she achieved the distinction of a National Level Gold Medallist. Contact her at: https://www.linkedin.com/in/saumya-multiplierai/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related